UNH Investors Have Opportunity to Join UnitedHealth Group Incorporated Fraud Investigation with the Schall Law Firm


Werte in diesem Artikel
Aktien

378.80 EUR -0.20 EUR -0.05 %

LOS ANGELES, May 19, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE: UNH) for violations of the securities laws.

(PRNewsfoto/The Schall Law Firm)

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. UnitedHealth is the subject of a Wall Street Journal article titled: "DOJ Investigates Medicare Billing Practices at UnitedHealth." According to the article, "The new civil fraud investigation is examining the company's practices for recording diagnoses that trigger extra payments to its Medicare Advantage plans, including at physician groups the insurance giant owns." Based on this news, shares of UnitedHealth fell by more than 8.4% in morning trading on February 21, 2025.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm 
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
www.schallfirm.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/unh-investors-have-opportunity-to-join-unitedhealth-group-incorporated-fraud-investigation-with-the-schall-law-firm-302458627.html

SOURCE The Schall Law Firm

Aktuelle UnitedHealth Aktie News

Werbung

UnitedHealth Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für UnitedHealth nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
14.04.22 UnitedHealth Outperform RBC Capital Markets
15.10.20 UnitedHealth Outperform Credit Suisse Group
14.10.20 UnitedHealth Outperform RBC Capital Markets
29.08.19 UnitedHealth Outperform Credit Suisse Group
17.07.18 UnitedHealth buy Goldman Sachs Group Inc.